Core Binding Factor Fusion Downregulation of ADAR2 RNA Editing Contributes to AML Leukemogenesis

Investigators found that adenosine deaminase acting on RNA (ADAR2), but not ADAR1 and ADAR3, was specifically downregulated in the core binding factor AML with t(8;21) or inv(16) translocations.